下调泛素样含PHD和环指域1基因的表达对喉癌Hep-2细胞增殖侵袭能力的影响

文韬宇; 祝琳; 刘亚男; 万婕; 雷越; 陈鸿雁

doi:10.16016/j.1000-5404.201612122

您当前的位置：

首页 >

文章列表页 >

下调泛素样含PHD和环指域1基因的表达对喉癌Hep-2细胞增殖侵袭能力的影响

基础医学 | 更新时间：2026-01-09

- 下调泛素样含PHD和环指域1基因的表达对喉癌Hep-2细胞增殖侵袭能力的影响
- Effect of down-regulation of UHRF1 on proliferation and invasive capacity in human laryngeal carcinoma Hep-2 cells
- 第三军医大学学报 2017年39卷第13期页码：1339-1344
- 作者机构：
  
  1.400016 重庆，重庆医科大学附属第一医院耳鼻喉科
  2.646000 四川泸州，西南医科大学附属医院耳鼻咽喉头颈外科
- 作者简介：
  
  [ 陈鸿雁，E-mail: chenhongyan1963@hotmail.com CHEN Hongyan,E-mail:chenhongyan1963@hotmail.com
- 基金信息：
  
  国家自然科学基金面上项目(81272980);国家临床重点专科建设项目(〔2012〕649)
- DOI：10.16016/j.1000-5404.201612122
  中图分类号： R73-37;R730.23;R739.65
- 收稿：2016-12-18，
  
  修回：2017-02-12，
  
  纸质出版：2017-07-15
- 稿件说明：
移动端阅览
文韬宇, 祝琳, 刘亚男, 等. 下调泛素样含PHD和环指域1基因的表达对喉癌Hep-2细胞增殖侵袭能力的影响[J]. 第三军医大学学报, 2017,39(13):1339-1344.

Taoyu WEN, Lin ZHU, Yanan LIU, et al. Effect of down-regulation of UHRF1 on proliferation and invasive capacity in human laryngeal carcinoma Hep-2 cells[J]. Journal of Third Military Medical University, 2017, 39(13): 1339-1344.
文韬宇, 祝琳, 刘亚男, 等. 下调泛素样含PHD和环指域1基因的表达对喉癌Hep-2细胞增殖侵袭能力的影响[J]. 第三军医大学学报, 2017,39(13):1339-1344. DOI： 10.16016/j.1000-5404.201612122.

Taoyu WEN, Lin ZHU, Yanan LIU, et al. Effect of down-regulation of UHRF1 on proliferation and invasive capacity in human laryngeal carcinoma Hep-2 cells[J]. Journal of Third Military Medical University, 2017, 39(13): 1339-1344. DOI： 10.16016/j.1000-5404.201612122.

摘要

目的

探讨下调泛素样含PHD和环指域1(ubiquitin-like protein containing PHD and RING finger domains 1，UHRF1) 基因在喉癌Hep-2细胞中的表达后对其增殖，凋亡，侵袭迁移能力的影响。

方法

实验分为空白组，阴性对照组和干扰组。利用UHRF1-siRNA干扰UHRF1在喉癌Hep-2细胞中的表达，采用qRT-PCR、Western blot检测UHRF1的表达变化。采用MTT法、流式细胞术、Transwell实验检测下调UHRF1表达后Hep-2细胞的增殖、凋亡、侵袭、迁移能力的变化。Western blot检测下调UHRF1表达后Hep-2细胞内Bax、Bcl-2、MMP-2、MMP-9蛋白表达的变化情况。

结果

与空白组和阴性对照组相比干扰组下调UHRF1的表达后可明显抑制喉癌Hep-2细胞的增殖能力(

＜0.001)。空白组，阴性对照组，干扰组凋亡率分别为(5.47±2.77)%，(3.95±0.66)%，(18.95±1.10)%，干扰组凋亡率明显提高(

＜0.001)。空白组，阴性对照，干扰组每视野侵袭细胞数分别为(213.7±13.1)，(221.3±10.3)，(97.7±7.5)，干扰组侵袭细胞数明显降低(

＜0.001)。空白组，阴性对照，干扰组每视野迁移细胞数分别为(230.7±5.5)，(222.7±11.2)，(111.7±7.6)，干扰组迁移细胞数明显降低(

＜0.001)。干扰组细胞Bax蛋白表达上调(

＜0.001)，Bcl-2蛋白表达下调(

＜0.001)，MMP-2蛋白、MMP-9蛋白表达下调(

＜0.001)。

结论

在喉癌Hep-2细胞中下调UHRF1的表达后可明显抑制细胞的增殖，促进细胞凋亡，抑制细胞的侵袭迁移能力。

Abstract

Objective

To determine the effect of down-regulation of ubiquitin-like protein containing PHD and ring finger domains 1 (UHRF1) on the proliferation

apoptosis

invasion and migration in human laryngeal carcinoma Hep-2 cell line.

Methods

The Hep-2 cells were randomly divided into 3 groups: blank control group

negative control group and tranfected group. UHRF1-siRNA was used to down-regulate the expression of UHRF1 in the Hep-2 cells

and quantitative real-time PCR (qRT-PCR) and Western blotting were used to detect the mRNA and protein expression of UHRF1 after down-regulation. The proliferative

invasive and migratory capabilities of Hep-2 cells transfected with UHRF1-siRNA were detected by MTT assay

flow cytometry and Transwell chamber assay. Western blotting was used to measure the protein levels of Bcl-2

Bax

MMP-2 and MMP-9.

Results

Compared with the blank control group and negative control group

down-regulation of UHRF1 significantly inhibited the proliferative capabilities of Hep-2 cells (

0.001). The apoptotic rate was (5.47±2.77)%

(3.95±0.66)% and (18.95±1.10)%

respectively in the blank control group

negative control group and transfected group

and the rate w

as the highest in the transfected group. The number of invasive cells was (213.7±13.1)

(221.3±10.3) and (97.7±7.5) respectively

and that of migratory cells was (230.7±5.5)

(222.7±11.2) and (111.7±7.6) respectively in the above 3 groups. The numbers of invasive and migratory cells were both obviously lower in the transfected group (

0.001). Western blotting results showed that Bax was up-regulated (

0.001)

and Bcl-2

MMP-2 and MMP-9 were down-regulated (

0.001).

Conclusion

Down-regulation of UHRF1 inhibits the proliferation

induces the apoptosis

and reduces the invasive and migratory capability in Hep-2 cells.

关键词

Keywords

references

孔维佳, 周梁, 许庚, 等.耳鼻咽喉头颈外科学[M].北京:人民卫生出版社, 2010:460-464.

KONG W J, ZHOU L, XU G, et al.Otorhinolaryngology-Head and Neck Surgery [M]. Beijing:People's Medical Publishing House, 2010:460-464.

BRONNER C, KRIFA M, MOUSLI M. Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis[J]. Biochem Pharmacol, 2013, 86(12): 1643-1649. DOI:10.1016/j.bcp.2013.10.002.

PI J T, LIN Y, QUAN Q, et al. Overexpression of UHRF1 is significantly associatedwith poor prognosis in laryngeal squamous cell carcinoma[J]. Med Oncol, 2013, 30(4): 613. DOI:10.1007/s12032-013-0613-9.

JENKINS Y, MARKOVTSOV V, LANG W, et al. Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth[J]. Mol Biol Cell, 2005, 16(12): 5621-5629. DOI:10.1091/mbc.E05-03-0194.

MOUSLI M, HOPFNER R, ABBADY A Q, et al. ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells[J]. Br J Cancer, 2003, 89(1): 120-127. DOI:10.1038/sj.bjc.6601068.

JIN W, CHEN L, CHEN Y, et al. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer[J]. Breast Cancer Res Treat, 2010, 123(2): 359-373. DOI:10. 1007/s10549-009-0652-2.

UNOKI M, DAIGO Y, KOINUMA J, et al. UHRF1 is a novel diagnostic marker of lung cancer[J]. Br J Cancer, 2010, 103(2): 217-222. DOI:10.1038/sj.bjc.6605717.

UNOKI M, KELLY J D, NEAL D E, et al. UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer[J]. Br J Cancer, 2009, 101(1): 98-105. DOI:10.1038/sj.bjc.6605123.

CUI L, CHEN J, ZHANG Q, et al. Up-regulation of UHRF1 by oncogenic Ras promoted the growth, migration, and metastasis of pancreatic cancer cells[J]. Mol Cell Biochem, 2015, 400(1-2): 223-232. DOI:10.1007/s11010-014-2279-9.

SABATINO L, FUCCI A, PANCIONE M, et al. UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression[J]. Oncogene, 2012, 31(49): 5061-5072. DOI:10.1038/onc.2012.3.

SABATINO L, FUCCI A, PANCIONE M, et al. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions[J]. Hum Pathol, 2005, 36(10): 1101-1107. DOI:10.1016/j.humpath.2005.07.016.

HOPFNER R, MOUSLI M, JELTSCH J M, et al. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression[J]. Cancer Res, 2000, 60(1): 121-128.

MULDER K W, WANG X, ESCRIU C, et al. Diverse epigenetic strategies interact to control epidermal differentiation[J]. Nat Cell Biol, 2012, 14(7): 753-763. DOI:10.1038/ncb2520.

WANG F, YANG Y Z, SHI C Z, et al. UHRF1 promotes cell growth and metastasis through repression of p16(inka) in colorectal cancer[J]. Ann Surg Oncol, 2012, 19(8): 2753-2762. DOI:10.1245/s10434-011-2194-1.

QIN Y, WANG J, GONG W, et al. UHRF1 depletion suppresses growth of gallbladder cancer cells through induction of apoptosis and cell cycle arrest[J]. Oncol Rep, 2014, 31(6): 2635-2643. DOI:10.3892/or.2014.3145.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

CPNE3调控非小细胞肺癌细胞增殖、迁移、侵袭及其相关机制研究

抑制GM130表达对胃癌细胞增殖、侵袭及迁移能力的影响

PCDH10基因在多发性骨髓瘤细胞中的作用

BMP-4基因影响乳腺癌细胞增殖、凋亡和迁移能力涉及NF-κB途径

RanBP9激活线粒体途径诱导骨肉瘤细胞凋亡